Imexpharm Corp
VN:IMP

Watchlist Manager

Imexpharm Corp

VN:IMP

Watchlist

Dividends

Discount Rate

Price: 48 650 VND -0.71%

Market Cap: 3.7T VND

Have any thoughts about
Imexpharm Corp?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 48650 VND

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

IMP Alert

Imexpharm Corp

48650

-350 (-0.71%)

52 Week Range	24 572.8953 53 200
Price Target

We'll email you a reminder when the closing price reaches VND.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Imexpharm Corp

What unique competitive advantages
does Imexpharm Corp hold over its rivals?

What risks and challenges
does Imexpharm Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Imexpharm Corp.

What unique competitive advantages
does Imexpharm Corp hold over its rivals?

What risks and challenges
does Imexpharm Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Imexpharm Corp.

Provide P/S
for Imexpharm Corp.

Provide P/E
for Imexpharm Corp.

Provide P/OCF
for Imexpharm Corp.

Provide P/FCFE
for Imexpharm Corp.

Provide P/B
for Imexpharm Corp.

Provide EV/S
for Imexpharm Corp.

Provide EV/GP
for Imexpharm Corp.

Provide EV/EBITDA
for Imexpharm Corp.

Provide EV/EBIT
for Imexpharm Corp.

Provide EV/OCF
for Imexpharm Corp.

Provide EV/FCFF
for Imexpharm Corp.

Provide EV/IC
for Imexpharm Corp.

Show me price targets
for Imexpharm Corp made by professional analysts.

What are the Revenue projections
for Imexpharm Corp?

How accurate were the past Revenue estimates
for Imexpharm Corp?

What are the Net Income projections
for Imexpharm Corp?

How accurate were the past Net Income estimates
for Imexpharm Corp?

What are the EPS projections
for Imexpharm Corp?

How accurate were the past EPS estimates
for Imexpharm Corp?

What are the EBIT projections
for Imexpharm Corp?

How accurate were the past EBIT estimates
for Imexpharm Corp?

Compare the revenue forecasts
for Imexpharm Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Imexpharm Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Imexpharm Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Imexpharm Corp compared to its peers.

Compare the P/E ratios
of Imexpharm Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Imexpharm Corp with its peers.

Analyze the financial leverage
of Imexpharm Corp compared to its main competitors.

Show all profitability ratios
for Imexpharm Corp.

Provide ROE
for Imexpharm Corp.

Provide ROA
for Imexpharm Corp.

Provide ROIC
for Imexpharm Corp.

Provide ROCE
for Imexpharm Corp.

Provide Gross Margin
for Imexpharm Corp.

Provide Operating Margin
for Imexpharm Corp.

Provide Net Margin
for Imexpharm Corp.

Provide FCF Margin
for Imexpharm Corp.

Show all solvency ratios
for Imexpharm Corp.

Provide D/E Ratio
for Imexpharm Corp.

Provide D/A Ratio
for Imexpharm Corp.

Provide Interest Coverage Ratio
for Imexpharm Corp.

Provide Altman Z-Score Ratio
for Imexpharm Corp.

Provide Quick Ratio
for Imexpharm Corp.

Provide Current Ratio
for Imexpharm Corp.

Provide Cash Ratio
for Imexpharm Corp.

What is the historical Revenue growth
over the last 5 years for Imexpharm Corp?

What is the historical Net Income growth
over the last 5 years for Imexpharm Corp?

What is the current Free Cash Flow
of Imexpharm Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Imexpharm Corp.

IMP

Income Statement

Selling, General & Administrative

Imexpharm Corp
Selling, General & Administrative

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Imexpharm Corp
Selling, General & Administrative Peer Comparison

Comparables:

DHT

DCL

DMC

DHG

TRA

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company		Selling, General & Administrative	CAGR 3Y	CAGR 5Y	CAGR 10Y
I	Imexpharm Corp VN:IMP	Selling, General & Administrative -₫405.6B	CAGR 3-Years -11%	CAGR 5-Years -7%	CAGR 10-Years -4%
H	HaTay Pharmaceutical JSC VN:DHT	Selling, General & Administrative -₫120.5B	CAGR 3-Years 1%	CAGR 5-Years 7%	CAGR 10-Years -4%
C	Cuu Long Pharmaceutical JSC VN:DCL	Selling, General & Administrative -₫136.1B	CAGR 3-Years 0%	CAGR 5-Years 6%	CAGR 10-Years N/A
D	Domesco Medical Import Export Joint Stock Corp VN:DMC	Selling, General & Administrative -₫194.6B	CAGR 3-Years 5%	CAGR 5-Years 13%	CAGR 10-Years 4%
D	Dhg Pharmaceutical Joint-Stock Co VN:DHG	Selling, General & Administrative -₫1.3T	CAGR 3-Years -9%	CAGR 5-Years 5%	CAGR 10-Years -1%
T	Traphaco JSC VN:TRA	Selling, General & Administrative -₫870.8B	CAGR 3-Years 16%	CAGR 5-Years 6%	CAGR 10-Years -7%

What is Imexpharm Corp's Selling, General & Administrative?

Selling, General & Administrative
-405.6B VND

Based on the financial report for Jun 30, 2024, Imexpharm Corp's Selling, General & Administrative amounts to -405.6B VND.

What is Imexpharm Corp's Selling, General & Administrative growth rate?

Selling, General & Administrative CAGR 10Y
-4%

Over the last year, the Selling, General & Administrative growth was 12%. The average annual Selling, General & Administrative growth rates for Imexpharm Corp have been -11% over the past three years , -7% over the past five years , and -4% over the past ten years .

Imexpharm Corp
VN:IMP

Imexpharm Corp
Selling, General & Administrative

Imexpharm Corp
Selling, General & Administrative Peer Comparison

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

See Also

What is Imexpharm Corp's Selling, General & Administrative?

Selling, General & Administrative
-405.6B VND

What is Imexpharm Corp's Selling, General & Administrative growth rate?

Selling, General & Administrative CAGR 10Y
-4%

Company

Help

Tools

Stocks

Imexpharm Corp VN:IMP

Imexpharm Corp Selling, General & Administrative

Imexpharm Corp Selling, General & Administrative Peer Comparison

Competitive Selling, General & Administrative Analysis Latest Figures & CAGR of Competitors

See Also

What is Imexpharm Corp's Selling, General & Administrative? Selling, General & Administrative -405.6B VND

What is Imexpharm Corp's Selling, General & Administrative growth rate? Selling, General & Administrative CAGR 10Y -4%

Company

Help

Tools

Stocks

Imexpharm Corp
VN:IMP

Imexpharm Corp
Selling, General & Administrative

Imexpharm Corp
Selling, General & Administrative Peer Comparison

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

What is Imexpharm Corp's Selling, General & Administrative?

Selling, General & Administrative
-405.6B VND

What is Imexpharm Corp's Selling, General & Administrative growth rate?

Selling, General & Administrative CAGR 10Y
-4%